zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - citas gremošanas trakta un metabolisma produkti, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
agil® 100 ec
adama - emulsijas koncentrāts - propakvizafops - herbicīdi
banjo forte®
adama - suspensijas koncentrāts - dimetomorfs + fluazinams - fungicīdi
goltix® 700 sc
adama - suspensijas koncentrāts - metamitrons - herbicīdi
legacy® 500 sc
adama - suspensijas koncentrāts - diflufenikans - herbicīdi
legacy® pro
adama - suspensijas koncentrāts - diflufenikans + hlorotolurons + pendametalīns - herbicīdi